H.R.2276: To require the Director of the United States Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive licensing exist, and for other purposes.

About this Bill

This bill was introduced in the 112th Congress
This bill is primarily about commerce
You can read the bill
Sponsor Debbie Wasserman Schultz, D-Fla.
Total Cosponsors 0
Introduced June 22, 2011
Latest Major Action Aug. 25, 2011
See it on GovTrack
See it on C-SPAN

Bill Progress

  • Bill introduced in the House   
  • Bill passed in the House   
  • Bill passed in the Senate   
  • Bill signed into law
No bill actions for H.R.2276 in the 112th Congress